Sen­a­tors ques­tion how HHS plans to roll out new drug pric­ing re­forms

While CMS drug price ne­go­ti­a­tions won’t ac­tu­al­ly kick off un­til 2026, a group of more than two dozen Re­pub­li­can sen­a­tors is al­ready rais­ing ques­tions about how this new law will be im­ple­ment­ed.

The par­ti­san law (all De­moc­rats in the House and Sen­ate vot­ed for it, and all Re­pub­li­cans vot­ed against it) in­cludes not on­ly Medicare price ne­go­ti­a­tions but manda­to­ry in­fla­tion-re­lat­ed re­bates that will be­gin next year, as well as mil­lion-dol­lar fines for non­com­pli­ance.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER